Cegedim SA

Half-year liquidity contract statement for CEGEDIM

09 Jan 2024 12:00:00 By Nasdaq GlobeNewswire

Cegedim: Growth continued in third quarter 2023

26 Oct 2023 11:45:00 By Nasdaq GlobeNewswire

Cegedim: Release of its 2023 Interim Financial Report

22 Sep 2023 11:45:00 By Nasdaq GlobeNewswire

Cegedim : Half-Year 2023 Earnings

20 Sep 2023 11:45:00 By Nasdaq GlobeNewswire

Cegedim: first-half 2023 revenues grew at a double-digit pace

27 Jul 2023 11:45:00 By Nasdaq GlobeNewswire

Cegedim: Half-year liquidity contract statement

04 Jul 2023 12:40:45 By Nasdaq GlobeNewswire

Cegedim off to a dynamic start in 2023

27 Apr 2023 11:50:00 By Nasdaq GlobeNewswire

Cegedim: Release of its 2022 Universal Registration Document

13 Apr 2023 12:00:00 By Nasdaq GlobeNewswire

Cegedim: Full year 2022 results

23 Mar 2023 12:45:00 By Nasdaq GlobeNewswire

Cegedim: revenue growth continued in 2022

26 Jan 2023 11:45:00 By Nasdaq GlobeNewswire

Cegedim: Half-year liquidity contract statement

04 Jan 2023 12:00:00 By Nasdaq GlobeNewswire

Cegedim: Growth continued in the third quarter of 2022

27 Oct 2022 11:45:00 By Nasdaq GlobeNewswire

Cegedim acquires French medical data expert Clinityx, strengthening its position in Real-World-Data

20 Oct 2022 11:45:00 By Nasdaq GlobeNewswire

Cegedim: Release of 2022 Half-Year Financial Report

20 Sep 2022 11:50:00 By Nasdaq GlobeNewswire

Cegedim: 1H 2022 Earnings

20 Sep 2022 11:45:00 By Nasdaq GlobeNewswire

Cegedim : Growth picked up speed in Q2 2022

28 Jul 2022 11:45:00 By Nasdaq GlobeNewswire

Cegedim: Half-year liquidity contract statement

25 Jul 2022 11:45:00 By Nasdaq GlobeNewswire

Cegedim: 2022 off to a promising start

28 Apr 2022 11:50:00 By Nasdaq GlobeNewswire

Cegedim: Release of its 2021 Universal Registration Document

04 Apr 2022 11:45:00 By Nasdaq GlobeNewswire

Cegedim full-year 2021 results: highly resilient business model

24 Mar 2022 12:45:00 By Nasdaq GlobeNewswire